What oral alternatives would you recommend as opposed to injectable GnRH agonists for those who do not wish to come to clinic due to COVID-19?
This applies to both de novo cases and patients who have previously received injectable agents.
Answer from: Radiation Oncologist at Community Practice
Casodex is an option. Due to liver toxicity, they would need LFTs checked before and at a future interval, effectively requiring them 3 visits to a health care facility—labs, pharmacy, labs. A single 6 month injection seems like a better proposition.
Comments
Radiation Oncologist at Abramson Cancer Center, University of Pennsylvania I agree with @Manuj Agarwal.
In addition, degarel...
Radiation Oncologist at Huntsman Cancer Institute - University of Utah Health Care Agreed. It's worth adding that the need for breast...
I agree with @Manuj Agarwal. In addition, degarel...
Agreed. It's worth adding that the need for breast...